Showing results (431-440 of 537) with videos related to

Sort By:
Pageof 54
European Journal of Neurology|January 5, 2021
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trialMessoud Ashina, Peter J Goadsby, Uwe Reuter, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 1, 2022
Sleep restriction alters cortical inhibition in migraine: A transcranial magnetic stimulation studyMartin Syvertsen Mykland, Martin Uglem, Jan Petter Neverdahl, et al.
Regional Anesthesia and Pain Medicine|May 24, 2022
Lidocaine infusions for refractory chronic migraine: a retrospective analysisEric S Schwenk, Aaron Walter, Marc C Torjman, et al.
Headache|January 9, 2021
Evaluation of the 6-item Identify Chronic Migraine screener in a large medical groupJelena M Pavlovic, Justin S Yu, Stephen D Silberstein, et al.
Regional Anesthesia and Pain Medicine|June 21, 2018
Ketamine for Refractory Headache: A Retrospective AnalysisEric S Schwenk, Amir C Dayan, Ashwin Rangavajjula, et al.
Headache|November 28, 2002
Reliability and validity of the migraine therapy assessment questionnaireMary Lou Chatterton, Jennifer H Lofland, Aaron Shechter, et al.
Headache|October 27, 2018
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine TrackerDavid W Dodick, Stewart J Tepper, Richard B Lipton, et al.
Nature Reviews. Disease Primers|January 14, 2022
MigraineMichel D Ferrari, Peter J Goadsby, Rami Burstein, et al.
Lancet (London, England)|November 18, 2023
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USADavid W Dodick, Peter J Goadsby, Todd J Schwedt, et al.
Headache|September 30, 2021
Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing dataDavid W Dodick, Stewart J Tepper, Jessica Ailani, et al.
Pageof 54